Fierce Healthcare

OCTOBER 4, 2023

Healthcare technology company Commure plans to merge with Athelas, a provider of healthcare workflow automation software, to grab a bigger piece of the health system market. The deal is backed by a $70 million investment from General Catalyst. The deal is backed by a $70 million investment from General Catalyst.

84

84

STAT

NOVEMBER 1, 2023

General Catalyst’s plan to take over a hospital in the coming months could be the first of many such deals, driven by financially strained hospitals looking for saviors, and venture capitalists convinced that they have the technology solutions for fixing the health care sector’s vexing problems.

Hospitals 123

Hospitals 123

pharmaphorum

OCTOBER 14, 2022

Biotech company Odyssey Therapeutics, Inc. has announced a $168 million Series B financing, led by global venture capital firm General Catalyst, an active investor in the healthcare sector. The Series B financing includes participation from all Series A investors and new investment from Fidelity Management & Research Company and T.

98

98

STAT

NOVEMBER 14, 2022

Women’s and family health tech startup Maven Clinic announced Monday it has raised $90 million in a Series E funding round led by General Catalyst, raising the company’s valuation to $1.35 Continue to STAT+ to read the full story…

89

89

NICE

FEBRUARY 2, 2022

The Digital Health Technology Catalyst, managed by UK Research and Innovation, is a £35 million fund run as part of the Medicines Manufacturing Challenge. It was created to help grow the digital health sector and address challenges identified in the Accelerated Access Review.

Packaging 52

Packaging 52

pharmaphorum

AUGUST 24, 2021

Digital health startup Breathe Well-being has raised $5.5 The Series A – led by US venture capital group Accel with participation from General Catalyst and Scott Shleifer, global managing director of hedge fund Tiger Global, which is a highly active investor in privately-held tech firms.

125

125

Pharmaceutical Technology

APRIL 11, 2023

Biotechnology company CTRL Therapeutics has announced $10m in seed financing to boost the development of a next-generation cell therapy platform to treat solid tumours. Led by General Catalyst, the financing round was supported by Intermountain Health, FACIT, and other investors.

Immunization 52

Immunization 52

pharmaphorum

NOVEMBER 1, 2021

Better Therapeutics has joined the ranks of publicly-listed digital health companies after completing a merger with blank cheque company Mountain Crest Acquisition Corp II. after the merger closed with the special purchase acquisition company (SPAC), but then rocketed to $16.76 in pre-market trading.

FDA 67

FDA 67

pharmaphorum

MAY 13, 2022

In my last article, I outlined the inflection point facing the pharmaceutical industry in digital health and the digital transformation of its clinical and commercial operations. This time I’m going to focus on one company and its view on pharma’s digital commercial strategy. Digital fluency and change.

Pharmaceutical Companies 125

Pharmaceutical Companies Pharmaceutical Companies Vaccines FDA 125

pharmaphorum

OCTOBER 28, 2021

Groups representing the biopharma industry have welcomed an increase in health-specific R&D to £5 billion in the UK autumn budget, despite a longer timeline for reaching the target of £22 billion in overall R&D spending. ” There have been high-profile cases of late involving UK companies who have claimed tax relief on projects.

Vaccines 106

Vaccines 106

pharmaphorum

MAY 11, 2022

US digital health firm Osmind – which had developed an electronic health record (EHR) system for patients with mental illness – has added to its finances with a $40 million Series B financing. We are excited to have @dfjgrowth on board and look forward to continuing our mission to transform mental health.

57

57

PQA

MARCH 28, 2024

The PQA Board of Directors completed the sale of all of PQA’s shares in Pharmacy Quality Solutions (PQS) to Innovaccer, a San Francisco, CA based healthcare technology company with a platform unifying patient data across systems and care settings. What Does this Mean for PQA? PQA remains steadfast in its commitment to our mission.

Immunization 40

Immunization 40

pharmaphorum

DECEMBER 14, 2021

Digital health startup Cadence has reached a heady $1 billion valuation just a few months after launch, thanks to a $100 million financing. Bloomberg reports that the lead investors from Cadence’s earlier funding round – General Catalyst and Thrive Capital – have also joined the latest financing.

Hospitals 52

Hospitals 52

pharmaphorum

MAY 27, 2021

Ada Health has received another endorsement for its app to help patients diagnose conditions from symptoms, raising an impressive $90 million in funding from investors including the venture capital arm of Bayer. . Various health systems, insurers, life sciences companies, and other organisations are already using it.

Insurance 74

Insurance 74

Pharmaceutical Technology

OCTOBER 26, 2022

Over recent years, many pharmaceutical companies have taken up environment, social and governance (ESG) targets in order to prioritize sustainability whilst boosting their external public relations. GlobalData is the parent company of Pharmaceutical Technology. However, in GlobalData’s 2021 Global Management Insight Survey, 58.4%

Insurance Coverage 64

Insurance Coverage Pharmaceutical Companies Pharmaceutical Companies Insurance 64

pharmaphorum

AUGUST 27, 2020

After three years at The Lancet , he moved agency-side, most recently serving as managing director at Health Unlimited. Bradley added: “Now more than ever, pharma companies need help understanding the role technology can play in their ‘new normal’ and how to effectively deploy it to increase audience engagement and understanding. “I

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

MAY 9, 2022

Mental health issues among teens and young adults have risen dramatically over the past decade. In primary care, there are guidelines to screening for behavioural health concerns like depression annually. However, a significant difficulty with today’s US health system is finding access directly to a mental health provider.

132

132

pharmaphorum

JUNE 30, 2021

During the last 10 years, investments in the health-tech sector trended between $2 to $5 billion. Fishawack Health talks to physician and AI informatics expert turned venture capitalist Sunny Kumar to learn how the healthcare technology landscape has changed because of COVID-19. The numbers speak for themselves.

52

52

pharmaphorum

JUNE 17, 2021

With an estimated 100,000 unfilled posts and staff turnover expected to increase due to emotional exhaustion, the health service’s workforce stands to be further stretched by an ageing population. Major crises are often the catalyst for innovation. more than the average 30-year-old.

111

111

pharmaphorum

JUNE 4, 2021

A recent analysis delves into the challenges companies face in getting digital health technologies reimbursed and presents recommendations for how these products can find a smoother path to market. The post “A long way to go” for digital health reimbursement appeared first on.

Compounding 44

Compounding FDA 44

Pharmaceutical Technology

NOVEMBER 30, 2022

Crossing the approval hurdle for a new drug is a big milestone for pharmaceutical companies. GlobalData is the parent company of Pharmaceutical Technology. The post CMO Moves: Regulatory Catalysts for Drug Manufacturing-November appeared first on Pharmaceutical Technology.

Packaging 52

Packaging FDA Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

DECEMBER 16, 2020

That had a significant impact on companies.”. We had companies collaborating to develop laboratories. We had companies sourcing consumables for testing machines. Luckily, Torbett says that there is a greater sense of certainty in the second wave, with “more of a rhythm” to what companies are doing. “We’ve

Vaccines 120

Vaccines 120

Roots Analysis

OCTOBER 31, 2023

It acted as a catalyst of change and led to rapid transformation of the healthcare system and the industry. Digital therapeutics or popularly known as DTx is one among the numerous digital health services which evolved out of it. The COVID-19 pandemic and its reverberation led to a paradigm shift in the healthcare industry.

FDA 40

FDA 40

pharmaphorum

JANUARY 15, 2021

Pharma’s reputation is currently riding high as the industry comes together to tackle COVID-19, but GSK’s UK general manager Neale Belson says there is always more companies can do to build their culture and make sure employees and customers trust they are doing the right thing. The same is true for the company’s Performance agenda.

Vaccines 104

Vaccines 104

pharmaphorum

MAY 23, 2022

Adele Waugaman, senior digital health coordinator of the COVID-19 response at the United States Agency for International Development (USAID), discusses the value of establishing donor partnerships and how those collaborations can improve digital health options globally. . Collaborative results.

Pharmaceutical Companies 82

Pharmaceutical Companies Pharmaceutical Companies Communication Vaccines 82

pharmaphorum

NOVEMBER 9, 2022

A £16 million Series A financing – led by Omega Funds – has been announced by the innovative neuroscience company NRG Therapeutics Ltd., for the purpose of advancing disease-modifying oral medicines for debilitating chronic neurodegenerative disorders, by enabling investigational new drugs (IND) studies.

Immunization 52

Immunization 52

pharmaphorum

JANUARY 26, 2023

In June 2022, NHS England (NHSE) and the National Institute for Health and Care Excellence (NICE) launched the Innovative Medicines Fund (IMF). We want to have conversations with companies as early as possible. Those costs are internal and reflect the fees that companies need to pay for at least two NICE appraisals.

57

57

pharmaphorum

MARCH 30, 2022

According to the partners, building the lab facility is just the first phase in the creation of what they hope will become a thriving location for life sciences companies on a 3.3 hectare site at North Quay in east London, which was recently given planning permission for development.

Pharmaceutical Companies 57

Pharmaceutical Companies Pharmaceutical Companies 57

Pharmaceutical Technology

JULY 14, 2022

Regulatory decisions have a ripple effect, first affecting the pharma sponsors, and then the companies tasked to manufacture the drug. In this ongoing series , we put a spotlight on contracts between pharma companies and contract manufacturing organizations (CMOs). To read the previous edition of this series, click here.

Vaccines 52

Vaccines Packaging FDA Pharmaceutical Companies 52

Pharmaceutical Technology

DECEMBER 12, 2022

Pharmaceutical companies often outsource different parts of the manufacturing process, including the production of small molecule active pharmaceutical ingredients (APIs) and parenteral packaging, to contract manufacturing organizations (CMOs). To re ad the previous editions in this series, click here, and here.

Packaging 59

Packaging Vaccines Pharmaceutical Companies Pharmaceutical Companies 59

pharmaphorum

MARCH 21, 2018

What does this mean for UK pharmaceutical companies that have historically focused on providing medicines and treatments? On one hand there are calls for them to change – going beyond being simply a supplier of products and moving into the role of partner, sharing risk to drive great health outcomes.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies 40

Fuld

APRIL 15, 2021

It is delivering prescriptions to patients rather than forcing them to go to a retail pharmacy, and it is providing a low-cost, hi-tech 24/7 on-body monitoring service backed up by leading-edge AI analytics to provide early disease detection and real-time health data. 2019 — Cerner, Amazon Care, and Health Navigator. Healthcare Market.

Health and Personal Care Stores 96

Health and Personal Care Stores Cerner Packaging Customer Service 96

pharmaphorum

DECEMBER 15, 2020

Graeme Duncan from ADVANZ PHARMA explores how successful cross-industry collaboration between pharma and generics companies has helped support supply challenges during the pandemic. The pandemic has further highlighted how research is not strictly limited to large, “innovator” pharmaceutical companies. A synergistic relationship.

Generic Medicine 70

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies Vaccines 70

pharmaphorum

NOVEMBER 15, 2022

The pandemic leaves myriad economic, social, health, and psychological scars in its wake. At Medidata, a Dassault Systèmes company, we saw these efforts first hand and now, two years on, we have taken stock of where our sector is. It caused intense suffering and tragedy.

Vaccines 102

Vaccines 102

Pharma Marketing Network

OCTOBER 13, 2020

With patients, you had a wave of Rx fills and refills earlier as many with chronic health conditions requiring ongoing Rx therapy stocked up on prescriptions in case they could not leave home – and safely get to a physician or pharmacy. Something similar is playing out in health care.

Hospitals 105

Hospitals Insurance Communication 105

Pharma Marketing Network

OCTOBER 11, 2021

Future ,” “Marketing Agility: The Path to Digital Engagement and Innovation, ” and “Digital Health: Where Is It Headed?” While the global outbreak of COVID-19 was the catalyst that pushed Pharma to innovate, think differently, and do things faster, we still aren’t moving fast enough in some areas.

Insurance 59

Insurance FDA 59

Pharma Marketing Network

OCTOBER 11, 2021

Future ,” “Marketing Agility: The Path to Digital Engagement and Innovation, ” and “Digital Health: Where Is It Headed?” While the global outbreak of COVID-19 was the catalyst that pushed Pharma to innovate, think differently, and do things faster, we still aren’t moving fast enough in some areas.

Insurance 52

Insurance FDA 52